Viral membrane proteins are the proteins of choice in vaccines but are difficult to produce quickly and reliably for use in vaccines, limiting rapid response during emerging outbreaks. Researchers ...
Elegen and Nutcracker Therapeutics launched a pilot program to demonstrate what they label the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results